Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Study finds lower vaccine uptake in children from certain socioeconomic and migration backgrounds October 10, 2025 CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma January 15, 2026 Reducing FTL1 protein levels reverses brain aging and improves memory in mice August 19, 2025
Study finds lower vaccine uptake in children from certain socioeconomic and migration backgrounds October 10, 2025
CTDNEP1 identified as potential tumor suppressor in pancreatic ductal adenocarcinoma January 15, 2026